Fundraising Fox

Zhizhong Yao

Investor

Partner at Sofinnova Partners

Paris, France

Writes $100K – $5M checks · typically $1.5M

About

Yao is a Partner in Sofinnova's Biovelocita Strategy, having joined in 2015 as an analyst focused on early-stage biotech and biopharmaceutical investments. He previously was a Human Frontier Science Program Cross-Disciplinary Fellow at the French National Institute of Agriculture Research and holds a PhD in Chemistry and Chemical Biology from Harvard and a Bachelor's from Peking University.

Invests in

Biotech

Experience

  1. Stealth StartupChief Executive Officercurrent2024 — presentParis, Île-de-France, France
  2. Sofinnova PartnersPartner - Sofinnova Acceleration Strategy BiovelocITAcurrent2023 — present
  3. Sofinnova PartnersPrincipal - Sofinnova Capital Strategy2015 — 2024Paris Area, France
  4. EnsocellDirector Board of Directors2023
  5. Mablink BioscienceBoard Observer2022 — 2023
  6. DISCO Pharmaceuticals GmbHDirector Board of Directors2022 — 2023
  7. GlycoEra AGBoard Observer2021 — 2023
  8. Mnemo therapeuticsBoard Observer2019 — 2023Paris Area, France
  9. Polyneuron Pharmaceuticals AGBoard Observer2019 — 2022Basel Area, Switzerland
  10. NodThera LimitedBoard Observer2018 — 2020Cambridge, United Kingdom
  11. French National Institute for Agricultural ResearchHuman Frontier Science Program (Cross-disciplinary Fellows)2013 — 2015Jouy-en-Josas, France

Education

  1. Kauffman Fellow2019 — 2024
  2. Harvard UniversityPhD, Chemistry and Chemical Biology/Systems Biology
  3. Peking UniversityBS, Chemistry and Molecular Engineering

Skills & more

Human Resources (HR)Business PlanningCRO ManagementGrant PreparationIntellectual PropertyBusiness DevelopmentBoard of DirectorsOperations ManagementDue DiligenceBoard Governancefund raisingVenture Capital
+2 moreboard directorsStrategic Planning

Languages Chinese · English · French

From Zhizhong's professional profile.

Same school

Shared employers

Investments

Board seats

DISCOEnsoCellGlycoERAMablink BioscienceMnemoNodthera

Per the firm's website.

Colleagues at Sofinnova Partners